Trademark: 87375224
Status Date
Monday, September 2, 2019
Filing Date
Friday, March 17, 2017
Published for Opposition
Tuesday, December 5, 2017
Abandoned Date
Monday, September 2, 2019
1 active chemical ingredients for use in the manufacture of anti-cancer drugs; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use
Sep 3, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 2, 2019
Abandonment - No Use Statement Filed
Feb 1, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 30, 2019
Extension 2 Granted
Jan 30, 2019
Extension 2 Filed
Jan 30, 2019
Teas Extension Received
Aug 1, 2018
Notice Of Approval Of Extension Request E-Mailed
Jul 30, 2018
Extension 1 Granted
Jul 30, 2018
Extension 1 Filed
Jul 30, 2018
Teas Extension Received
Jan 30, 2018
Noa E-Mailed - Sou Required From Applicant
Dec 5, 2017
Official Gazette Publication Confirmation E-Mailed
Dec 5, 2017
Published For Opposition
Nov 15, 2017
Notification Of Notice Of Publication E-Mailed
Nov 2, 2017
Approved For Pub - Principal Register
Oct 20, 2017
Teas/Email Correspondence Entered
Oct 20, 2017
Correspondence Received In Law Office
Oct 2, 2017
Assigned To Lie
Sep 25, 2017
Teas Response To Suspension Inquiry Received
Jun 16, 2017
Notification Of Letter Of Suspension E-Mailed
Jun 16, 2017
Letter Of Suspension E-Mailed
Jun 16, 2017
Suspension Letter Written
Jun 15, 2017
Examiner's Amendment Entered
Jun 15, 2017
Notification Of Examiners Amendment E-Mailed
Jun 15, 2017
Examiners Amendment E-Mailed
Jun 15, 2017
Examiners Amendment -Written
Jun 12, 2017
Assigned To Examiner
Mar 22, 2017
New Application Office Supplied Data Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
